158 related articles for article (PubMed ID: 35348047)
1. "We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States.
Dubé K; Kanazawa J; Roebuck C; Johnson S; Carter WB; Dee L; Peterson B; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Shipley L; Bateman K; Howell BJ; Mounzer K; Tebas P; Montaner LJ
HIV Res Clin Pract; 2022 Dec; 23(1):120-135. PubMed ID: 35348047
[TBL] [Abstract][Full Text] [Related]
2. Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions.
Dubé K; Agarwal H; Carter WB; Dee L; Taylor J; Roebuck C; Peterson B; Patel H; Ndukwe S; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Bateman K; Howell BJ; Azzoni L; Mounzer K; Tebas P; Montaner LJ
HIV Res Clin Pract; 2022 Aug; 23(1):76-90. PubMed ID: 35968737
[No Abstract] [Full Text] [Related]
3. Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States.
Dubé K; Eskaf S; Hastie E; Agarwal H; Henley L; Roebuck C; Carter WB; Dee L; Taylor J; Mapp D; Campbell DM; Villa TJ; Peterson B; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Shipley L; Bateman K; Howell BJ; Mounzer K; Tebas P; Montaner LJ
J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207719
[TBL] [Abstract][Full Text] [Related]
4. Perspectives on Analytical Treatment Interruptions in People Living with HIV and Their Health Care Providers in the Landscape of HIV Cure-Focused Studies.
Lau JSY; Smith MZ; Allan B; Martinez C; Power J; Lewin SR; McMahon JH
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):260-267. PubMed ID: 31608648
[TBL] [Abstract][Full Text] [Related]
5. "It comes altogether as one:" perceptions of analytical treatment interruptions and partner protections among racial, ethnic, sex and gender diverse HIV serodifferent couples in the United States.
Campbell DM; Dubé K; Cowlings PD; Dionicio P; Tam RM; Agarwal H; Stockman JK; Auerbach JD; Sauceda JA; Conroy AA; Johnson MO
BMC Public Health; 2022 Jul; 22(1):1317. PubMed ID: 35810288
[TBL] [Abstract][Full Text] [Related]
6. Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States.
Bilger A; Plenn E; Barg FK; Rendle KA; Carter WB; Lamour-Harrington A; Jones N; Peterson B; Sauceda JA; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dubé K
HIV Res Clin Pract; 2023 Oct; 24(1):2267825. PubMed ID: 37837376
[TBL] [Abstract][Full Text] [Related]
7. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research.
Dubé K; Kanazawa J; Dee L; Taylor J; Campbell DM; Brown B; Johnson MO; Saberi P; Sauceda JA; Sugarman J; Peluso MJ
HIV Res Clin Pract; 2021 Feb; 22(1):14-30. PubMed ID: 33757411
[No Abstract] [Full Text] [Related]
8. 'With this study, we have hope that something is coming': community members' perceptions of HIV cure-related research in Durban, South Africa - a qualitative focus group study.
Dubé K; Mthimkhulu D; Ngcobo W; Mindry D; Maphalala L; Pillay V; Tran W; Korolkova A; Ndung'u T; Dong K
HIV Res Clin Pract; 2023 Jul; 24(1):2243046. PubMed ID: 37555592
[TBL] [Abstract][Full Text] [Related]
9. Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.
Dubé K; Kanazawa J; Campbell C; Boone CA; Maragh-Bass AC; Campbell DM; Agosto-Rosario M; Stockman JK; Diallo DD; Poteat T; Johnson M; Saberi P; Sauceda JA
AIDS Res Hum Retroviruses; 2022 Jan; 38(1):50-63. PubMed ID: 33947268
[TBL] [Abstract][Full Text] [Related]
10. Understanding participant perspectives around HIV-1 cure-related studies involving antiretroviral analytical treatment interruptions in the United Kingdom.
Lee MJ; Godakandaarachchi P; Collins S; Racz M; Sharp A; Fidler S; Fox J
J Virus Erad; 2023 Dec; 9(4):100360. PubMed ID: 38188642
[TBL] [Abstract][Full Text] [Related]
11. Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States.
Dubé K; Ndukwe SO; Korolkova A; Dee L; Sugarman J; Sauceda JA
HIV Res Clin Pract; 2024 Jan; 25(1):2312318. PubMed ID: 38348830
[TBL] [Abstract][Full Text] [Related]
12. "We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.
Dubé K; Evans D; Dee L; Sylla L; Taylor J; Skinner A; Weiner BJ; Greene SB; Rennie S; Tucker JD
AIDS Res Hum Retroviruses; 2018 Jan; 34(1):67-79. PubMed ID: 28562069
[TBL] [Abstract][Full Text] [Related]
13. "I Would Absolutely Need to Know That My Partner Is Still Going to be Protected": Perceptions of HIV Cure-Related Research Among Diverse HIV Serodifferent Couples in the United States.
Dubé K; Agarwal H; Stockman JK; Auerbach JD; Sauceda JA; Conroy AA; Johnson MO
AIDS Res Hum Retroviruses; 2023 Aug; 39(8):400-413. PubMed ID: 35972752
[TBL] [Abstract][Full Text] [Related]
14. Fee for home delivery and monitoring of antiretroviral therapy for HIV infection compared with standard clinic-based services in South Africa: a randomised controlled trial.
Barnabas RV; Szpiro AA; Ntinga X; Mugambi ML; van Rooyen H; Bruce A; Joseph P; Ngubane T; Krows ML; Schaafsma TT; Zhao T; Tanser F; Baeten JM; Celum C; van Heerden A;
Lancet HIV; 2022 Dec; 9(12):e848-e856. PubMed ID: 36335976
[TBL] [Abstract][Full Text] [Related]
15. Community HIV clinicians' perceptions about HIV cure-related research in the Northwestern United States.
Sylla L; Patel H; Louella M; Simoni J; Dubé K
HIV Res Clin Pract; 2022 Jul; 23(1):61-75. PubMed ID: 35904107
[No Abstract] [Full Text] [Related]
16. Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011.
Martin DA; Luz PM; Lake JE; Clark JL; Veloso VG; Moreira RI; Cardoso SW; Klausner JD; Grinsztejn B
BMC Infect Dis; 2014 Jun; 14():322. PubMed ID: 24919778
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review and Meta-analysis of Treatment Interruptions in Human Immunodeficiency Virus (HIV) Type 1-infected Patients Receiving Antiretroviral Therapy: Implications for Future HIV Cure Trials.
Stecher M; Claßen A; Klein F; Lehmann C; Gruell H; Platten M; Wyen C; Behrens G; Fätkenheuer G; Vehreschild JJ
Clin Infect Dis; 2020 Mar; 70(7):1406-1417. PubMed ID: 31102444
[TBL] [Abstract][Full Text] [Related]
19. One size does not fit all: Preferences for HIV care delivery among out-of-care people living with HIV in the Southeastern United States.
Jones MD; Dyer K; Nedell ER; Fletcher MR; Grimsley Ackerley C; Hussen SA; Kalokhe AS
PLoS One; 2023; 18(1):e0276852. PubMed ID: 36649350
[TBL] [Abstract][Full Text] [Related]
20. "This Is Actually a Really Unique Moment in Time": Navigating Long-Acting HIV Treatment and HIV Cure Research with Analytical Treatment Interruptions-A Qualitative Interview Study in the United States.
Dubé K; Perez-Brumer A; Patel H; Zhou C; Dee L; Graham G; Meanley S; Philbin MM
AIDS Res Hum Retroviruses; 2024 Mar; ():. PubMed ID: 38386494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
